Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19

Name: Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19
Creator: Moretti, Alessandra; Gnecchi, Massimiliano; Mura, Manuela; Crotti, Lia; Sala, Luca; Schwartz, Peter J; Giannetti, Federica; Khudiakov, Aleksandr; Leonov, Vladislav
Published: 2022-01-27T00:00:00+08:00